Correlation Between Grifols SA and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Grifols SA and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grifols SA ADR and Novartis AG, you can compare the effects of market volatilities on Grifols SA and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and Novartis.

Diversification Opportunities for Grifols SA and Novartis

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Grifols and Novartis is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and Novartis AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG has no effect on the direction of Grifols SA i.e., Grifols SA and Novartis go up and down completely randomly.

Pair Corralation between Grifols SA and Novartis

Given the investment horizon of 90 days Grifols SA is expected to generate 1.17 times less return on investment than Novartis. In addition to that, Grifols SA is 1.31 times more volatile than Novartis AG. It trades about 0.02 of its total potential returns per unit of risk. Novartis AG is currently generating about 0.03 per unit of volatility. If you would invest  8,047  in Novartis AG on August 27, 2024 and sell it today you would earn a total of  2,353  from holding Novartis AG or generate 29.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.52%
ValuesDaily Returns

Grifols SA ADR  vs.  Novartis AG

 Performance 
       Timeline  
Grifols SA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Grifols SA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Novartis AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Grifols SA and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Grifols SA and Novartis

The main advantage of trading using opposite Grifols SA and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Grifols SA ADR and Novartis AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
CEOs Directory
Screen CEOs from public companies around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon